Reuters.- An advisory committee to the U.S. Centers for Disease Control and Prevention (CDC) recommended a booster dose of Pfizer and BioNTech’s Covid-19 vaccine for Americans 65 and older and for some adults with illnesses. that put them at serious risk.
The panel did not want to recommend boosters for adults between the ages of 18 and 64 who live or work in institutions with a high risk of contracting Covid-19, such as health personnel, teachers and those residing in homeless shelters and prisons.
Follow the information about business and current affairs in Forbes Mexico
Some members of the group cited the difficulty of executing the proposal.
The group’s vote, following Food and Drug Administration (FDA) approval, clears the way for the booster deployment to begin as early as this week for millions of people who received their second dose of the vaccine. from Pfizer for at least six months.
The CDC indicated that about 26 million people in the United States received the second Pfizer / BioNTech vaccine at least six months ago, including 13 million age 65 and older.
Follow us on Google News to keep you always informed